Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000576149 | SCV000671732 | pathogenic | Hereditary cancer-predisposing syndrome | 2016-10-21 | criteria provided, single submitter | clinical testing | The p.R74* pathogenic mutation (also known as c.220A>T), located in coding exon 4 of the PTEN gene, results from an A to T substitution at nucleotide position 220. This changes the amino acid from an arginine to a stop codon within coding exon 4. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |